This bill prohibits the federal government from funding any research that studies the effects of gender-related medical treatments, which the legislation defines to include various surgical procedures, hormone therapies, and puberty blockers. The prohibition applies broadly to any research that examines how these medical interventions affect individuals, whether conducted directly by federal agencies or supported indirectly through grants to universities, research institutions, or other organizations. The bill would impact medical researchers, academic institutions, and government health agencies like the National Institutes of Health that currently conduct or fund studies in this area. No specific funding amount or implementation timeline is included in the legislation, as it simply prohibits the use of existing federal research dollars for this category of work. The bill was introduced in August 2026 and referred to the Committee on Energy and Commerce.